Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.
Multiple sclerosis: Efficacy of fingolimod confirmed on all MRI end points.
Analyzing differences between patient and proxy on Patient Reported Outcomes in multiple sclerosis.
Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation.
Optical coherence tomography as a biomarker in multiple sclerosis.
Social and economic burden of walking and mobility problems in multiple sclerosis.
Age of Onset as a Moderator of Cognitive Decline in Pediatric-Onset Multiple Sclerosis.
Efficacy and safety of cutting balloons for the treatment of obstructive lesions in the internal jugular veins.
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
Novel Kv1.3 blockers for immunosuppression: W02012155199.
Acute Disseminated Encephalomyelitis: The Time Until Diagnosis and Its Subsequent Course in Children.
Elevated HSP27 levels during attacks in patients with multiple sclerosis.
NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms.
Living with multiple sclerosis.
Hematopoietic progenitors express myelin basic protein and ensheath axons in Shiverer brain.
Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?
Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling.
Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real Life Setting.
Sex-related differences of cAMP-specific PDE4B3 mRNA in oligodendrocytes following systemic inflammation.
Cognitive impairment and optic nerve axonal loss in patients with clinically isolated syndrome.
Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses.
Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.
Vowel Acoustics in Parkinson's disease and Multiple Sclerosis: Comparison of Clear, Loud and Slow Speaking Conditions.
Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS).
Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains.
Pages
« first
‹ previous
…
268
269
270
271
272
273
274
275
276
…
next ›
last »